Company intelligence / Profile preview

S32

Palo Alto, California, United Statess32.com ↗

Ownership: Private
Development stage: Other

Overview

S32 is a leading Silicon Valley-based venture capital firm investing at the frontiers of technology and healthcare. Founded by Bill Maris (ex-Google Ventures), it manages over $2 billion across multiple funds and focuses on accelerating the discovery, development, adoption, and distribution of revolutionary technologies—including biotechnology, therapeutics, advanced diagnostics, precision medicine, software/AI/ML—that improve the human condition. The team includes experienced leaders from both tech and biotech sectors. Its portfolio includes investments in notable life science startups such as Thrive Earlier Detection (acquired by Exact Sciences), Vir Biotechnology, Relay Therapeutics, BigHat Bio, Function Oncology, ROME Therapeutics and Sunbird Bio.

Industry: Investors

Beyond the preview

Go deeper on S32.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S32.

Explore the full profile